That has spread to other parts of the body or cannot be removed by surgery, and whose tumor is KRAS G12C positive, and who have received at least one prior treatment.1
HOW DOES LUMAKRAS® WORK?
- LUMAKRAS® is specifically designed for tumors with the KRAS G12C mutation in non-small cell lung cancer (NSCLC)1
- In tumors with this KRAS mutation, the protein remains mostly in an “on” position, and cells are continuously forced to grow2
- LUMAKRAS® targets the mutated KRAS molecule and locks it in the “off” position. This may prevent tumor cell growth3